Vivoryon Therapeutics N.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
20 aug 2015 - 10:00
Statutory name
Vivoryon Therapeutics N.V.
Title
Probiodrug AG to Publish First Half 2015 Results on 27 August, 2015
Comments
HALLE/SAALE, Germany, 20 August 2015 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), will publish its results for the first six months 2015 on August 27, 2015. The company will host a conference call open to the public on August 27, 2015 at 15:00 Central European Time (CET).
Date last update: 25 July 2025